↓ Skip to main content

Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial

Overview of attention for article published in European Journal of Cancer (1965), January 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

blogs
1 blog
twitter
16 X users
facebook
2 Facebook pages

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial
Published in
European Journal of Cancer (1965), January 2021
DOI 10.1016/j.ejca.2020.12.005
Pubmed ID
Authors

Fernando Rivera, Marta Izquierdo-Manuel, Pilar García-Alfonso, Eva Martínez de Castro, Javier Gallego, María Luisa Limón, María Alsina, Luis López, Maica Galán, Esther Falcó, José Luis Manzano, Encarna González, Nerea Muñoz-Unceta, Carlos López, Enrique Aranda, Eva Fernández, Mónica Jorge, Paula Jiménez-Fonseca

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 6 12%
Researcher 5 10%
Other 4 8%
Student > Bachelor 3 6%
Student > Doctoral Student 3 6%
Other 12 24%
Unknown 16 33%
Readers by discipline Count As %
Medicine and Dentistry 15 31%
Unspecified 6 12%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Biochemistry, Genetics and Molecular Biology 3 6%
Nursing and Health Professions 2 4%
Other 2 4%
Unknown 18 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 June 2021.
All research outputs
#2,244,310
of 25,732,188 outputs
Outputs from European Journal of Cancer (1965)
#535
of 6,923 outputs
Outputs of similar age
#62,598
of 534,506 outputs
Outputs of similar age from European Journal of Cancer (1965)
#18
of 105 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,923 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 534,506 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 105 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.